ARS Pharmaceuticals (SPRY) Depreciation and Depletion (2020 - 2024)
ARS Pharmaceuticals (SPRY) posted Depreciation and Depletion of $29000.0 for Q4 2024, up 38.1% sequentially from $21000.0 in Q3 2024, and up 141.67% YoY from $12000.0 in Q1 2024.
ARS Pharmaceuticals (SPRY) Depreciation and Depletion (2020 - 2024) Analysis & Trends
ARS Pharmaceuticals has reported Depreciation and Depletion for 5 years, with the latest figure at $29000.0 in Q4 2024.
- Quarterly Depreciation and Depletion rose 141.67% year-over-year to $29000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $79000.0 (up 8.22% YoY) and the FY2024 annual result came in at $79000.0, up 8.22% from the prior year.
- Depreciation and Depletion grew to $29000.0 in Q4 2024 per SPRY's latest filing, from $21000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $209000.0 in Q2 2021 and troughed at -$37000.0 in Q2 2022.
- A 5-year average of $79300.0 and a median of $25000.0 in 2023 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2022 and 2023: Depreciation and Depletion sank 117.7% in 2022, then jumped 200.0% in 2023.
- Over 5 years, Depreciation and Depletion stood at $152000.0 in 2020, then soared by 34.21% to $204000.0 in 2021, then slumped by 93.14% to $14000.0 in 2022, then decreased by 14.29% to $12000.0 in 2023, then jumped by 141.67% to $29000.0 in 2024.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $29000.0, $21000.0, and $18000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | ARS Pharmaceuticals | 561.88 Mn | 418.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 29,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |